Xiamen Kingdomway Group Co., Ltd. 2025 H1 Earnings Forecast Analysis Current Period Performance Forecast The company forecasts a 70% to 100% year-over-year increase in net profit for the first half of 2025 2025 H1 Earnings Forecast | Item | Current Period (Jan 1 - Jun 30, 2025) | Same Period Last Year | | :--- | :--- | :--- | | Net Profit Attributable to Shareholders | Profit: 221.14 – 260.17 (RMB million) | Profit: 130.08 (RMB million) | | YoY Growth | 70% – 100% | - | | Net Profit After Non-recurring Items | Profit: 219.80 – 258.59 (RMB million) | Profit: 129.30 (RMB million) | | YoY Growth | 70% – 100% | - | | Basic Earnings Per Share (EPS) | Profit: 0.36 – 0.42 (RMB/Share) | Profit: 0.21 (RMB/Share) | Communication with the Accounting Firm The company has preliminarily communicated with its auditor on the forecast with no major disagreements - This earnings forecast is unaudited, but the company has preliminarily communicated with its accounting firm on related major matters, and no significant disagreements exist4 Explanation of Performance Changes Performance growth is primarily driven by increased sales of key products and domestic healthcare business - The main drivers of performance growth were increased sales of Coenzyme Q10, Vitamin A, and domestic healthcare products5 Risk Warning and Explanation The company confirms no major uncertainties affecting the forecast but notes the data is unaudited - The company confirms no significant uncertainties exist that would affect the accuracy of this earnings forecast6 - This forecast is a preliminary estimate by the finance department and is unaudited; final data will be based on the official 2025 semi-annual report, and investors should be aware of investment risks78
金达威(002626) - 2025 Q2 - 季度业绩预告